What is VOR's P/E ratio?

Vor Biopharma Inc (VOR) currently trades at a P/E ratio of 0.69.

Vor Biopharma Inc reports a Return on Equity (ROE) of 587.06%.

What is VOR's dividend yield?

Vor Biopharma Inc offers a dividend yield of 0.00%.

What is VOR's Quality Score?

Our AI rates VOR's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy VOR?

Our AI Timing Score for VOR is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does VOR belong to?

Vor Biopharma Inc is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Vor Biopharma Inc (VOR) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

VOR AI Analysis Summary

Our AI summary for VOR: Vor Biopharma Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.69, ROE of 587.06%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

VOR

Vor Biopharma Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 93

USD 21.15

-0.65 (-2.98%) Day Change

Watchlist Portfolio Compare Chart

0.69

P/E

0.00

D/E

587.1%

ROE

-174.3%

ROA

0.00%

Div Yield

0.03

PEG

VOR BIOPHARMA INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 21.15 Price -0.65 (-2.98%) Day Change	NEWS SCORE: 93

VOR, the overall quality is not good ( Quality = 46) but the timing to buy is ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

54%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	93
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	21.15
PBV / Sector	-7.85 / 5.20
Earning Per Share	-15.81

PE / Sector	0.69 / 19.97 GREAT
PEG or PE/Growth / Sector	0.03 / 1.22 GREAT
Average 1M Daily Value	21.49 M GREAT
Average 1W Daily Value	18.34 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.71
NPM Average (%) / Sector	N/A / -1,721.76
NPM Change Average (%) / Sector	N/A / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-174.26 / 27.02
ROA Average (%) / Sector	-98.59 / -368.17
ROA Change Average (%) / Sector	56.94 / 5,404.12 GREAT
ROE (%) / Sector	587.06 / 3.47 GREAT
ROE Average (%) / Sector	154.95 / 6.51 GREAT
ROE Change Average (%) / Sector	-61.04 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 08:00:40
Symbol	VOR
Name	VOR BIOPHARMA INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	54.19 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,181.25 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 500 Boylston Street, Boston, MA, United States, 02116

Phone: 617 655 6580

Website: https://www.vorbio.com

Employees: 76

Sector: Healthcare >> Biotechnology

Description: Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.